Novel 18F-labeled benzoxazole derivatives as potential positron emission tomography probes for imaging of cerebral β-amyloid plaques in alzheimers disease

Mengchao Cui, Masahiro Ono, Hiroyuki Kimura, Masashi Ueda, Yuji Nakamoto, Kaori Togashi, Yoko Okamoto, Masafumi Ihara, Ryosuke Takahashi, Boli Liu, Hideo Saji

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Two radiofluoro-pegylated phenylbenzoxazole derivatives, 4-(5-(2-(2-(2-[ 18F]fluoroethoxy)ethoxy)ethoxy)benzo[d]oxazol-2-yl)-N- methylaniline ([ 18F]24) and 4-(5-(2-(2-(2-[ 18F] fluoroethoxy)ethoxy)ethoxy)benzo[d]oxazol-2-yl)-N,N-dimethylaniline ([ 18F]32), were synthesized and evaluated as probes for imaging cerebral β-amyloid (Aβ) plaques in living brain tissue by PET. [ 18F]24 and [ 18F]32 displayed high affinity for Aβ 1-42 aggregates (K i = 9.3 and 3.9 nM, respectively). In vitro autoradiography with sections of post-mortem AD brain and transgenic mouse brain confirmed the affinity of these tracers. Initial high uptake into and rapid washout from the brain in normal mice were observed. [ 18F]24 also displayed excellent binding to Aβ plaques in ex vivo autoradiographic experiments with Tg2576 mice. Furthermore, small-animal PET studies demonstrated significant differences in the clearance profile after the administration of [ 18F]24 between Tg2576 and wild-type mice. The results suggest [ 18F]24 to be a useful PET agent for detecting Aβ plaques in the living human brain.

Original languageEnglish
Pages (from-to)9136-9145
Number of pages10
JournalJournal of Medicinal Chemistry
Volume55
Issue number21
DOIs
Publication statusPublished - Nov 8 2012
Externally publishedYes

Fingerprint

Benzoxazoles
Amyloid Plaques
Positron-Emission Tomography
Alzheimer Disease
Brain
Autoradiography
Transgenic Mice

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Novel 18F-labeled benzoxazole derivatives as potential positron emission tomography probes for imaging of cerebral β-amyloid plaques in alzheimers disease. / Cui, Mengchao; Ono, Masahiro; Kimura, Hiroyuki; Ueda, Masashi; Nakamoto, Yuji; Togashi, Kaori; Okamoto, Yoko; Ihara, Masafumi; Takahashi, Ryosuke; Liu, Boli; Saji, Hideo.

In: Journal of Medicinal Chemistry, Vol. 55, No. 21, 08.11.2012, p. 9136-9145.

Research output: Contribution to journalArticle

Cui, Mengchao ; Ono, Masahiro ; Kimura, Hiroyuki ; Ueda, Masashi ; Nakamoto, Yuji ; Togashi, Kaori ; Okamoto, Yoko ; Ihara, Masafumi ; Takahashi, Ryosuke ; Liu, Boli ; Saji, Hideo. / Novel 18F-labeled benzoxazole derivatives as potential positron emission tomography probes for imaging of cerebral β-amyloid plaques in alzheimers disease. In: Journal of Medicinal Chemistry. 2012 ; Vol. 55, No. 21. pp. 9136-9145.
@article{94506c1d4d984121adcca8f283d28d73,
title = "Novel 18F-labeled benzoxazole derivatives as potential positron emission tomography probes for imaging of cerebral β-amyloid plaques in alzheimers disease",
abstract = "Two radiofluoro-pegylated phenylbenzoxazole derivatives, 4-(5-(2-(2-(2-[ 18F]fluoroethoxy)ethoxy)ethoxy)benzo[d]oxazol-2-yl)-N- methylaniline ([ 18F]24) and 4-(5-(2-(2-(2-[ 18F] fluoroethoxy)ethoxy)ethoxy)benzo[d]oxazol-2-yl)-N,N-dimethylaniline ([ 18F]32), were synthesized and evaluated as probes for imaging cerebral β-amyloid (Aβ) plaques in living brain tissue by PET. [ 18F]24 and [ 18F]32 displayed high affinity for Aβ 1-42 aggregates (K i = 9.3 and 3.9 nM, respectively). In vitro autoradiography with sections of post-mortem AD brain and transgenic mouse brain confirmed the affinity of these tracers. Initial high uptake into and rapid washout from the brain in normal mice were observed. [ 18F]24 also displayed excellent binding to Aβ plaques in ex vivo autoradiographic experiments with Tg2576 mice. Furthermore, small-animal PET studies demonstrated significant differences in the clearance profile after the administration of [ 18F]24 between Tg2576 and wild-type mice. The results suggest [ 18F]24 to be a useful PET agent for detecting Aβ plaques in the living human brain.",
author = "Mengchao Cui and Masahiro Ono and Hiroyuki Kimura and Masashi Ueda and Yuji Nakamoto and Kaori Togashi and Yoko Okamoto and Masafumi Ihara and Ryosuke Takahashi and Boli Liu and Hideo Saji",
year = "2012",
month = "11",
day = "8",
doi = "10.1021/jm300251n",
language = "English",
volume = "55",
pages = "9136--9145",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "21",

}

TY - JOUR

T1 - Novel 18F-labeled benzoxazole derivatives as potential positron emission tomography probes for imaging of cerebral β-amyloid plaques in alzheimers disease

AU - Cui, Mengchao

AU - Ono, Masahiro

AU - Kimura, Hiroyuki

AU - Ueda, Masashi

AU - Nakamoto, Yuji

AU - Togashi, Kaori

AU - Okamoto, Yoko

AU - Ihara, Masafumi

AU - Takahashi, Ryosuke

AU - Liu, Boli

AU - Saji, Hideo

PY - 2012/11/8

Y1 - 2012/11/8

N2 - Two radiofluoro-pegylated phenylbenzoxazole derivatives, 4-(5-(2-(2-(2-[ 18F]fluoroethoxy)ethoxy)ethoxy)benzo[d]oxazol-2-yl)-N- methylaniline ([ 18F]24) and 4-(5-(2-(2-(2-[ 18F] fluoroethoxy)ethoxy)ethoxy)benzo[d]oxazol-2-yl)-N,N-dimethylaniline ([ 18F]32), were synthesized and evaluated as probes for imaging cerebral β-amyloid (Aβ) plaques in living brain tissue by PET. [ 18F]24 and [ 18F]32 displayed high affinity for Aβ 1-42 aggregates (K i = 9.3 and 3.9 nM, respectively). In vitro autoradiography with sections of post-mortem AD brain and transgenic mouse brain confirmed the affinity of these tracers. Initial high uptake into and rapid washout from the brain in normal mice were observed. [ 18F]24 also displayed excellent binding to Aβ plaques in ex vivo autoradiographic experiments with Tg2576 mice. Furthermore, small-animal PET studies demonstrated significant differences in the clearance profile after the administration of [ 18F]24 between Tg2576 and wild-type mice. The results suggest [ 18F]24 to be a useful PET agent for detecting Aβ plaques in the living human brain.

AB - Two radiofluoro-pegylated phenylbenzoxazole derivatives, 4-(5-(2-(2-(2-[ 18F]fluoroethoxy)ethoxy)ethoxy)benzo[d]oxazol-2-yl)-N- methylaniline ([ 18F]24) and 4-(5-(2-(2-(2-[ 18F] fluoroethoxy)ethoxy)ethoxy)benzo[d]oxazol-2-yl)-N,N-dimethylaniline ([ 18F]32), were synthesized and evaluated as probes for imaging cerebral β-amyloid (Aβ) plaques in living brain tissue by PET. [ 18F]24 and [ 18F]32 displayed high affinity for Aβ 1-42 aggregates (K i = 9.3 and 3.9 nM, respectively). In vitro autoradiography with sections of post-mortem AD brain and transgenic mouse brain confirmed the affinity of these tracers. Initial high uptake into and rapid washout from the brain in normal mice were observed. [ 18F]24 also displayed excellent binding to Aβ plaques in ex vivo autoradiographic experiments with Tg2576 mice. Furthermore, small-animal PET studies demonstrated significant differences in the clearance profile after the administration of [ 18F]24 between Tg2576 and wild-type mice. The results suggest [ 18F]24 to be a useful PET agent for detecting Aβ plaques in the living human brain.

UR - http://www.scopus.com/inward/record.url?scp=84868593540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868593540&partnerID=8YFLogxK

U2 - 10.1021/jm300251n

DO - 10.1021/jm300251n

M3 - Article

C2 - 22690944

AN - SCOPUS:84868593540

VL - 55

SP - 9136

EP - 9145

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 21

ER -